[{"AccountsPayableCurrent_0_Q2_USD":2045000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":3795000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":7900000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3859000.0,"OtherLiabilitiesCurrent_0_Q2_USD":3421000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-27726000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":12686000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":125500000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":1422000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":146100000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-276000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":249000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.89,"EarningsPerShareDiluted_1_Q2_USD":-0.23,"ProceedsFromStockOptionsExercised_2_Q2_USD":1685000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":249000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-276000.0,"OperatingLeaseExpense_2_Q2_USD":3400000.0,"OperatingLeaseExpense_1_Q2_USD":1700000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-32695000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-8957000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":103000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-4568000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":36996390.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":37029524.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":638000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":5378000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1147215.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4492000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":30184000.0,"ProceedsFromSaleOfProductiveAssets_2_Q2_USD":31000.0,"MarketableSecuritiesCurrent_0_Q2_USD":85349000.0,"RestrictedCash_0_Q2_USD":1779000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":482000.0,"PreferredStockValueOutstanding_0_Q2_USD":null,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":14987000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-854000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":26988000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":29183000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3421000.0,"OperatingLeaseLiability_0_Q2_USD":32604000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":10246000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2980000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":6138000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":6323000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":15.55,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":6512000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":14190000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":42850000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-139000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":122856000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":43911000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":59323000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":229700000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":86771000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":86295000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":475000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":122000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":1324000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":346000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":6707000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2988988.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":3334000.0,"NonoperatingIncomeExpense_2_Q2_USD":470000.0,"StockholdersEquity_0_Q2_USD":76884000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-345592000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":20205000.0,"ProfitLoss_2_Q2_USD":-32944000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4301000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3389000.0,"NetIncomeLoss_2_Q2_USD":-32944000.0,"NetIncomeLoss_1_Q2_USD":-8681000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-49999000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":107155000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":2167000.0,"LiabilitiesCurrent_0_Q2_USD":67531000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":297455000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":18154000.0,"Liabilities_0_Q2_USD":220571000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2025000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":18444000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":8239000.0,"Depreciation_2_Q2_USD":1768000.0,"CommonStockValue_0_Q2_USD":37000.0,"CommonStockSharesOutstanding_0_Q2_shares":37203627.0,"CommonStockSharesIssued_0_Q2_shares":37203627.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":144321000.0,"AssetsCurrent_0_Q2_USD":246657000.0,"Assets_0_Q2_USD":297455000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":6779376.0,"AdditionalPaidInCapital_0_Q2_USD":422294000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":145000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-995000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":28681000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockSharesAuthorized_0_Q2_shares":120000000.0,"NonoperatingIncomeExpense_1_Q2_USD":300000.0,"EarningsPerShareBasic_2_Q2_USD":-0.89,"EarningsPerShareBasic_1_Q2_USD":-0.23,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1603000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":12.33,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":10.31,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":15.38,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5893175.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":16.59,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":407853.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-854000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-46000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1333000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":36996390.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1651000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":163513.0,"ShareBasedCompensation_2_Q2_USD":7900000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":61718000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":29423000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingIncomeLoss_2_Q2_USD":-33414000.0,"OperatingIncomeLoss_1_Q2_USD":-8981000.0,"OperatingExpenses_2_Q2_USD":80162000.0,"OperatingExpenses_1_Q2_USD":37662000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":37029524.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":46748000.0,"Ticker":"VYGR","CIK":"1640266","name":"VOYAGER THERAPEUTICS, INC.","OfficialName":"Voyager Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"363614047.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]